News
Voiant Launches Voiant Hub 2.0 at ASCO: Setting a New Standard in Clinical Trial Imaging
WALTHAM, Mass. / PRNewswire-PRWeb Voiant announced today the release of Voiant Hub 2.0 at the 2025 ASCO Annual Meeting. Voiant Hub,…
Voiant Acquires Voxeleron to Expand Ophthalmic Clinical Research with AI Technology
WALTHAM, Mass. / PRNewswire-PRWeb Voiant, a leader in clinical trial imaging solutions, today is announcing the acquisition of Voxeleron, a…
Voiant Delivers Primary Endpoints in Two New Drug Approvals for Colorectal Cancer and Glioma Following Successful FDA Inspections
WALTHAM, Mass. / PRNewswire-PRWeb Voiant, the industry’s leading AI-driven clinical trial imaging solution provider, is proud to announce that the…
Voiant Boosts Ophthalmology Imaging Services, Doubling Reader Capacity
WALTHAM, Mass. / PRNewswire-PRWeb Voiant, a leader in clinical trial imaging solutions, today announced significant enhancements to its ophthalmology imaging…
Voiant’s Commitment to Quality Affirmed by FDA Inspection with No Findings Raised
WALTHAM, Mass. / PRNewswire-PRWeb Voiant, a leader in clinical trial imaging solutions, is proud to announce the successful completion of…
MedQIA, WorldCare Clinical and DARC Merge to Form Voiant, LLC: A New Paradigm in AI-Driven Clinical Trial Imaging
WALTHAM, Mass. / PRNewswire-PRWeb Today, industry leaders MedQIA, WorldCare Clinical and DARC are excited to announce their merger and the…